If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Omvoh ® (mirikizumab-mrkz) injection
300 mg/15 mL, 100 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is Omvoh® (mirikizumab-mrkz) available in a prefilled syringe?
The US Food and Drug Administration approved the administration of mirikizumab via prefilled syringe on April 29, 2024. Pharmacies will not stock the product, but it is available for pharmacies to order as of June 2024.
Enclosed Prescribing Information
Date of Last Review: June 12, 2024